Neogen Chemicals Q2 FY27: revenue up 41.8% to ₹296 Cr, net profit up 144.2% to ₹8 Cr
Results · Finvezto · 2 Nov 2026 · Neogen Chemicals (NEOGEN)
Results Q2 FY27, ₹ Cr
| Q2 FY27 | ₹ Cr | QoQ | YoY |
|---|---|---|---|
| Revenue | 296 | - | +41.8% |
| Operating profit | 45 | - | +51.3% |
| Net profit | 8 | - | +144.2% |
| Operating margin | 15.3% | - | +1.0 pp |
| Net margin | 2.8% | - | +1.2 pp |
YoY is the company's own figure. QoQ shows where our quarterly series matches the filing.
Key points
- Consolidated revenue grew 42% year-on-year to INR 296 crore in Q2 FY27, while EBITDA increased 51% to INR 45 crore and profit after tax rose 144% to INR 8 crore. Earnings call
- Battery chemicals revenue reached INR 37 crore in Q2 FY27 compared to INR 5 crore in Q2 FY26, driven by scaling up of lithium-ion electrolyte salts. Earnings call
- The Board approved doubling Organolithium capacity at Patancheru from 300 MTPA to 600 MTPA with a capital outlay of up to INR 45 crore, targeting completion by H1 FY28. Earnings call
What to watch
- Management on base business revenue: With the way the second quarter has gone, in Q3/Q4, we feel we would be INR 50 crore to INR 100 crore more as compared to what we guided earlier.
- Management on fy28 base business revenue: And for the next year also, we can enhance our guidance because we would also have the Organolithium capacity, which we just announced, which was not taken into consideration.
Links
Company page · Results tracker
Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630.